Mini Curriculum Vitae

Cécile GUILLON

PhotoGUILLON
Equipe : Fonctionnalité et dynamique du tissu cutané
Courriel : Cecile.GUILLON@ibcp.fr
Téléphone : +33(0)4-37-65-29-09
Statut : Doctorant


2017
5.  Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo. 
Verrier B, Paul S, Terrat C, Bastide L, Ensinas A, Phelip C, Chanut B, Bulens-grassigny L, Jospin F, Guillon C
(2017) Front Immunol 8 :770-770  Icon PUBMED

2016
4.  Multi-inhibitor prodrug constructs for simultaneous delivery of anti-inflammatory agents to mustard-induced skin injury. 
Lacey Cj, Wohlman I, Guillon C, Saxena J, Fianu-velgus C, Aponte E, Young Sc, Heck De, Joseph Lb, Laskin Jd, Heindel Nd
(2016) Ann N Y Acad Sci 1378 :174-179  Icon PUBMED

3.  Mustard vesicants alter expression of the endocannabinoid system in mouse skin. 
Wohlman Im, Composto Gm, Heck De, Heindel Nd, Lacey Cj, Guillon Cd, Casillas Rp, Croutch Cr, Gerecke Dr, Laskin Dl, Joseph Lb, Laskin Jd
(2016) Toxicol Appl Pharmacol 303 :30-44  Icon PUBMED

2007
2.  Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits. 
Guillon C, Mayol K, Terrat C, Compagnon C, Primard C, Charles Mh, Delair T, Munier S, Verrier B
(2007) Vaccine 25 :7491-501  Icon PUBMED

2002
1.  Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08. 
Verrier B, Le Grand R, Ataman-onal Y, Terrat C, Guillon C, Durand Py, Hurtrel B, Aubertin Am, Sutter G, Erfle V, Girard M
(2002) Dna Cell Biol 21 :653-8  Icon PUBMED